Doug has more than fifteen years’ experience as an intellectual property (IP) and brand licensing strategist and IP valuation professional. Doug is an accomplished writer, speaker, and is part of the International Trademark Association’s (INTA) Internet Committee and the ICANN Compliance and Domain Name Industry Subcommittee. Doug is a Certified Licensing Professional (CLP) and is a Founding Principal of Nevium Intellectual Property Solutions and Managing Director of Brand Finance USA. Doug is also a branding, licensing and IP damages expert and has been a named in approximately 50 cases, has been deposed ten times and has provided trial testimony five times.
Doug holds an MA in Television Film and New Media with an emphasis on marketing from San Diego State University and a BA in Cinema from San Francisco State University. His writings have appeared in peer-reviewed journals such as the Journal of Intellectual Property Law and other publications such as The World Trademark Review and a book chapter in Calculating Economic Damages in Intellectual Property Infringement Cases published by Business Valuation Resources (BVR).
Tamlin Bason is an associate for Bloomberg Intelligence, where he follows litigation and policy developments related to the technology and telecommunications sectors. Bloomberg Intelligence is a research platform that provides in-depth analysis and data sets on industries and companies, as well as the government, credit, litigation and economic factors that can impact decision-making. Prior to Bloomberg Intelligence, Tamlin was a legal editor for Bloomberg BNA's Patent, Trademark & Copyright Journal. Tamlin received his undergraduate degree from Virginia Tech and his juris doctor from the Catholic University of America.
Mr. Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker and consultant in the technology and healthcare industries. He currently serves as the founding President and CEO of Innovation America (IA), a national public-private partnership focused on accelerating the growth of innovation economy in America. As one of the most recognized experts in the field of innovation economy, Mr. Bendis has served on numerous distinguished boards and task forces including the White House U.S. Innovation Partnership Advisory Task Force, the Small Business Innovation Research Committee, the National Association of State Venture Funds board; State Science and Technology Institute, and the Ernst and Young Entrepreneurial Institute as a national/regional Judge.
Mr. Bendis has provided global consulting services to over 16 countries and 22 states, several cities and regions, along with international organizations including the United Nations, NATO, UK Trade and Industry, European Commission, French Embassy, the German Marshall Fund, The Canadian Consulate, METI, AKEA, the International Science Parks and Innovation Expert Group and other global entities. Mr. Bendis is a frequent consultant and speaker to 16 International innovation based economic development organizations, as well as over 20 states, regions and cities throughout the U.S. He was voted one of the Top 5 Speakers on innovation economy in 2012.
John Carney serves as the Director of Commercialization & Licensing atDelphi Automotive Systems, LLC. His career in the automotive business spans 37 years, with a background in finance, sales, marketing and program management. He successfully completed four divestitures as a deal director during Delphi’s 2005 -2009 restructuring effort. John joined the Delphi licensing activity in 2009, where he is currently the director of the worldwide licensing and IP monetization efforts.
John holds a BA in Accounting and an MBA in Finance from Indiana University and is a CLP. He is currently the Secretary of the A and T committee for the HTS.
A member of the Executive Committee of the Licensing Executives Society, Faith L. Charles leads Thompson Hine's Life Sciences Group and is a partner in their Corporate Transactions & Securities and International practices. Faith represents technology companies in the life sciences and health care sectors, providing guidance on organization and acquisition of technology through private financing, public securities offerings, mergers and acquisitions, strategic collaborations, and SEC reporting.
Faith has served on boards of directors, and currently sits on the board of a developer of immunotherapies to combat cancer and targeted vaccines. Additionally, Faith is the founder and current Chair of the New York Metro chapter of Women in Bio and a member of Springboard Enterprises. She also serves on the board of directors of Gilda’s Club NYC and as an Advisory Board member of the Rothman Institute of Innovation and Entrepreneurship at Fairleigh Dickinson University.
Peter is the manager of the Pacific Northwest National Laboratory’s technology commercialization group, which is part of PNNL’s Technology Deployment and Outreach department. This group is responsible for the identification, protection, and management of intellectual property created at the Laboratory, and they are responsible for the licensing and deployment of these technologies.
Prior to joining PNNL, Peter worked as a patent attorney and as the VP of engineering and intellectual property for a leading PEM fuel cell developer. Peter has also worked for an energy consulting company where he helped large industrial users prepare for and take advantage of the increasingly complex and changing electrical power markets.
Peter holds a Bachelor of Science degree in electrical engineering from the University of Minnesota and a juris doctor from the University of New Hampshire School of Law (formerly Franklin Pierce Law Center) in Concord, New Hampshire.
Michael J. Dansky, Managing Director in charge of BRG Capstone’s Boston Office and National Leader of BRG Capstone’s Intellectual Property Practice, has more than 30 years of experience in intellectual property valuation, licensing and intellectual property transactions and dispute resolution. Throughout his career, Mr. Dansky has focused on developing strategies for maximizing the value of assets and executing licensing and related transactions to monetize these assets and well as evaluating and calculating damages and assessing transaction related issues in a wide range of litigation and dispute related matters.
Mr. Dansky has assessed, commercialized, valued and licensed technologies and intellectual property portfolios and evaluated intellectual property damages in a wide range of industries and in many technical disciplines from complex electronics, materials, semiconductors and computer hardware and software to chemicals, food products, pharmaceuticals, biotechnology and alternative energy from bio sources. He has significant experience with patents, trademarks, brands, copyrights, know-how, and trade secrets, as well as accounting, finance and a wide range of transactional related matters. Mr. Dansky is an internationally recognized expert in the business and conduct of licensing and the valuation of intellectual property, having run the licensing and intellectual property businesses at multiple large corporations. He has testified in State, Federal, and Bankruptcy Courts and before Federal Administrative Agencies and in many arbitrations on a number of dispute and litigation matters with issues involving the quantum of damages, accounting and financial issues, asset valuation and a range of transactional matters. In addition to negotiating and executing many transactions in a number of industries and drafting many licensing and related agreements, Mr. Dansky has performed due diligence for buyers, sellers, and financing entities for a number of significant transactions.
Mr. Dansky was formerly a Principal at the Brattle Group and the founder of Intellectual Property Strategies, a full service intellectual property advisory firm. He has also previously been a Managing Director at Huron Consulting Group and was Vice President for Corporate Strategy and Business Development at Polaroid Corporation, where he had worldwide, corporate responsibility for Technology Licensing and leveraging the Polaroid patent and technology portfolio. Prior to Polaroid, Mr. Dansky was an executive for Amoco and Xerox Corporations, with senior level licensing and business development transaction responsibilities, and a partner at two international consulting firms. While at Amoco and Xerox, Mr. Dansky had worldwide responsibility for: licensing and commercializing the Companies’ intellectual property portfolios; mergers, acquisitions and divestitures; and in-licensing and open innovation efforts, among a range of other duties.
Education and Affiliations
Mr. Dansky holds an M.B.A. in International Business/Finance from The George Washington University and a BA in Economics and Political Science from Tufts University. IAM Magazine has recognized him as one the World’s 250 Top IP Strategists in each year of its publication. Mr. Dansky has been a long time member of the Licensing Executives Society (LES) and for many years chaired LES’s flagship Technology Transfer Educational Program, teaching IP valuation and licensing negotiations. Mr. Dansky is formerly the Chair of the ABA’s Economics Committee.
Kathleen A. Denis is the Associate Vice President of Technology Transfer at The Rockefeller University, a premier biomedical research institution located in New York City. Managing the intellectual assets of the University, she works with their elite group of researchers to establish partnerships with industry in order to develop and commercialize technologies for the public good. She is a Past President of the Licensing Executives Society USA/Canada (LES), and has served on the Board of Directors of the Association of University Technology Managers (AUTM) and the Pennsylvania Biotechnology Association. She is a Certified Licensing Professional, a former Chair of the Board of Governors of Certified Licensing Professionals, Inc. and a Registered Technology Transfer Professional (RTTP).
Formerly a consultant specializing in the management of intellectual assets in the life sciences, she worked with academic and industry clients to manage intellectual property portfolios, evaluate new technologies, market and license technologies and start new technology-based businesses. Dr. Denis is active in numerous professional organizations and speaks frequently about early stage technology evaluation, formation of start-up companies, conflict of interest and other issues of academic technology transfer.
From 1995 through 1998 Dr. Denis was Vice President, Technology Development at Allegheny Health, Education and Research Foundation. She managed the intellectual property and research assets of the Medical College of Pennsylvania and Hahnemann University, as well as Allegheny General Hospital and Allegheny Singer Research Institute. Responsibilities of this position included the evaluation and marketing of technologies, building collaborative relationships with the biomedical and biopharmaceutical communities and promotion of economic development in Pennsylvania.
Dr. Denis was a Director at the University of Pennsylvania Center for Technology Transfer from 1991 to 1995, where she managed a large portfolio of biotechnology and pharmaceutical related technologies. Previously, she was an investigator at the Molecular Biology Institute at UCLA for eight years, and a Senior Scientist at Specialty Laboratories, Inc. She has over thirty scientific publications.
Dr. Denis holds a Ph.D. in immunology from the University of Pennsylvania, an M.A. in Human Genetics from University of Texas Medical Branch at Galveston and an undergraduate degree in genetics from Cornell University.
John Favreau is a champion of brand management and marketing, corporate development and strategy, operational improvements and business re-engineering. He has broad, deep and international experience in all areas of deal flow, including M&A, divestitures, licensing, collaborations, consolidations and joint ventures.
Mr. Favreau leads Little Lake Partners, LLC, an exclusive consulting firm that provides strategic, financial and brand management and marketing capabilities to solve problems and create greater opportunities for growth oriented businesses, including start-ups and joint ventures. Little Lake Partner’s clients include US and International fashion, apparel, accessories and beauty brands, consumer household product companies, and other lifestyle oriented services and businesses. Prior to founding Little Lake Partners, John led Corporate Development and Strategy for Itochu International Inc., AT&T Capital, and CFSG, Inc.
Mr. Favreau, a Wharton Graduate has contributed at the Board level of 12 companies. He is an Adjunct Professor at LIM College and lectures on Luxury Brand Management at Parsons.
Gillian M. Fenton is a seasoned executive with 30 years’ experience in the biopharmaceutical industry. Gillian joined GSK Vaccines in April 2016 and is presently responsible for managing a portfolio of R&D contracts with the U.S. Government, as well as leading pipeline acquisitive transactions for the Slaoui Center for Vaccines Research, GSK’s new R&D Center in Rockville MD. Prior to joining GSK, Gillian was Chief Intellectual Property Counsel at Emergent BioSolutions Inc.. While at EBS, Gillian founded the IP department, oversaw all IP activities in support of EBS’s IPO and its subsequent strategy of growth through M&A. Prior to joining EBS, Gillian was in-house IP counsel at Biogen Inc., where she led all IP activities in support of BIIB’s launch of its second biologic product, AMEVIVE® (alefacept). Gillian also has significant experience in private practice. B.Sc., Biochemistry, Trinity College, Hartford CT; J.D. cum laude, Suffolk University Law School, Boston MA.
Prior to her new appointment, Nicoletta was Chief, FOCI Operations Division. Ms. Giordani’s responsibilities include the management of the DSS FOCI mitigation and compliance programs. She reports directly to Mr. Gortler.
Manage a team that informs and advises senior leadership on opportunities and/or challenges to the industrial base from foreign direct investment, global market trends, and technology prospects through engagement with internal and external stakeholders. This includes evaluating and reviewing mergers and acquisitions by foreign acquirers for potential national security concerns and collaborating with the Committee on Foreign Investment in the United States on matters related to foreign investment into the National Industrial Security Program.
David Greenwald, Ph.D., currently serves as Director of Corporate Relations for Johns Hopkins Technology Ventures (JHTV). Dr. Greenwald is a founder of Relay Technology Management, Inc. and co-inventor of the Relay Innovation Engine software. Dr. Greenwald was previously Chief Executive Officer of Relay Technology Management and Director of Client Solutions for Decision Resources Group (DRG) after its acquisition of Relay. Dr. Greenwald was a Howard Hughes Medical Institute (HHMI) research fellow while earning a B.S. in Cellular Biology and Molecular Genetics from the University of Maryland, College Park and was awarded an NIH Ruth L. Kirschstein National Research Service Award (NRSA) towards his Ph.D. research dissertation on gene therapy for Retinitis Pigmentosa, which he completed at Tufts University School of Medicine. Dr. Greenwald lectures on Entrepreneurial Finance and Corporate Finance at The Johns Hopkins Carey Business School, where he is an adjunct faculty.
Joseph V. Gulfo, MD, MBA, is Executive Director of the Lewis Center for Healthcare Innovation and Technology at Fairleigh Dickinson University (FDU) where he is spearheading the Initiative for Patient-Centered Innovation and also serves as a Professor of Health Sciences. He is a senior fellow with the Progressive Policy Institute and is the author of The Care Quotient: Transforming Business Through People (September 2016) and Innovation Breakdown: How the FDA and Wall Street Cripple Medical Advances (June 2014). He Previously a Visiting Scholar at the George Mason University’s Mercatus Center, he was author of the white paper, The Proper Role of the FDA for the 21st Century. Dr. Gulfo teaches graduate cancer biology and maintains a cancer biology blog. Prior to this, he served as President & CEO of MELA Sciences (2004-2013), and was Chairman of the Board (2011-2013).
Jonathon Hance focuses his practice on energy and intellectual property litigation, with an emphasis on complex commercial disputes relating to energy-supply agreements, including International Swaps and Derivatives Association (ISDA) Master Agreements in the oil and gas, liquefied natural gas (LNG), trading and marketing, renewable, solar, chemical and petrochemical industries. His litigation practice also includes cases of patent infringement, trademark infringement and misappropriation of trade secrets in the areas of software, open-source code, mobile devices, computer hardware, gTLDs (generic top-level domain names) and network infrastructures. Jonathon represents an array of international clients in the energy, oil and gas, technology, software, media, advertising, radio, banking, payment processing, retail, transportation, medical, food and beverage and aerospace and defense industries.
In addition to his litigation practice, Jonathon focuses on the licensing of intellectual property, including patents, copyrights, trademarks, trade secrets, and know how relating to advanced computer-implemented technology, including computer software programs, database architectures, computer interfaces and business systems. He is also actively engaged in technology transfer in the advanced-technology sector with particular emphasis on computer implemented systems and methods incorporating advanced mathematical algorithms. With a background in financial derivatives and mathematical modeling, Jonathon is able to assist clients in the protection, licensing or transferring financial models, business methods, and other intellectual property assets. He has also conducted intellectual property and software due diligence for numerous mergers, acquisitions and investment transactions.
Jonathon served as a judicial clerk to the Honorable Jennifer Walker Elrod of the United States Court of Appeals for the Fifth Circuit. Prior to the practice of law, Jonathon served as the director of information and technology for a mid-size restaurant company where he actively participated in key technology and business decisions relating to corporate back-end computing services, point-of-sale and point-of-transaction systems and web-interface design. He also served as a mathematical consultant for the Bank of America Private Bank where he developed financial portfolio projection and analysis software using the Monte Carlo method.
Honorable Faith Hochberg is a nationally recognized former U.S. District Judge known for her broad expertise in complex corporate, securities, antitrust and intellectual property litigation. Hochberg ADR provides mediation, arbitration and strategic litigation advisory services. Judge Hochberg also serves as a distinguished neutral on the rosters of AAA, ICDR, Federal Arbitration, CPR, WIPO, ITC and ICC.
In her prior career, Judge Hochberg was a United States Attorney and Deputy Assistant Secretary of the Treasury. Additional career experience information is available at, www.JudgeHochberg.com.
Judge Hochberg graduated from Harvard Law School, magna cum laude, where she was an Editor of the Harvard Law Review. She received her undergraduate degree from Tufts University, summa cum laude, and attended the London School of Economics.
Chad Huston practiced law between 1984 and 1990 with Arnold, White & Durkee focusing on prosecution, licensing and litigation, with an emphasis on software issues. Chad was CEO of ProShot Golf, Inc. 1995-1998 and was responsible for private financing (investment bank private placement), patent litigation, and strategic relations including international joint ventures. Chad practices law as a partner with Egan Peterman Enders & Huston in Austin, Texas focusing on patent related issues. Chad is a past president of the Austin Intellectual Property Law Association and the Austin Corporate Counsel Chapter.
Chad has been active in startup companies as a legal advisor, founder and investor. Chad owns and operates Solomoar, an augmented and virtual reality development company.
Chad is retired from the Air Force Reserve and is a fighter pilot with over 2500 hours in 10 types of fighter aircraft, including combat experience.
Greg is a former trial and appellate attorney with the Department of Justice, where he represented the U.S. government in commercial and white collar fraud matters. His practice focuses in the areas of government contracts, export controls, trade sanctions, and FCPA and related anti-corruption laws. Greg counsels clients on M&A transactions, investigations, and trial and appellate litigation.
Stephen Kabakoff practices all aspects of patent law, including litigation, PTAB post grant proceedings, licensing and portfolio management, patent preparation and prosecution, opinions, and client counseling. His work is primarily focused on technology relating to electrical and computer engineering and materials science. He also maintains a robust transactional practice, including licensing and settlement negotiations and due diligence analyses for mergers and acquisitions. He is a frequent presenter on licensing topics.
Scott Kamholz is a former Administrative Patent Judge. He handled over 120 AIA trials while a member of the PTAB. He is now Of Counsel at Covington & Burling LLP in Washington DC and specializes in PTAB trial practice. Dr. Kamholz holds a BS in biomedical engineering, a Ph.D. in stem cell biology, and an M.D. degree from the University of Miami, and a JD from Boston College Law School.
Efrat Kasznik is an intellectual property valuation and strategy expert, with 20 years of consulting experience, focusing on assisting companies of all sizes and across industries with the management and commercialization of their IP and technologies. Ms. Kasznik is the president of Foresight Valuation Group, a Silicon-Valley based IP valuation, strategy, and start-up advisory firm. She is an appointed Lecturer on IP Management at the Stanford Graduate School of Business (GSB), where she has been teaching since 2011. Ms. Kasznik has been actively involved with LES leadership roles, and has recently been elected Secretary of the High Tech Sector of LES USA-Canada. Ms. Kasznik has been listed on the IAM 300 list of World Leading IP Strategists for four years in a row, since 2013. She is a frequent author and speaker on topics related to IP strategy and valuation. Throughout her career, Ms. Kasznik has also been a founder and CFO of Silicon Valley startups, and she currently serves on the advisory boards of several startups, accelerators and venture funds in the US, Europe and Israel.
Ms. Kennedy is a registered patent attorney currently practicing out of the Washington, DC office of Kilpatrick Townsend & Stockton. Her practices focuses on all aspects of patent prosecution and post grant proceedings in the chemical and medical device arts. She earned a J.D. from the Columbus School of Law at the Catholic University of America, and a B.S. in Chemistry from Randolph-Macon College.
The Honorable F. Scott Kieff became a Commissioner of the U.S. International Trade Commission on October 18, 2013, after having been nominated by President Obama and confirmed by the Senate.
Before swearing in, he took a leave of absence from serving as Fred C. Stevenson Research Professor at the George Washington University Law School in Washington, DC; and resigned from Stanford University’s Hoover Institution, where he was the Ray & Louise Knowles Senior Fellow.
He previously taught at Washington University in Saint Louis, as a Professor in the School of Law with a secondary appointment in the School of Medicine’s Department of Neurological Surgery.
He practiced law as a trial lawyer and patent lawyer with law firms in New York and Chicago and served as a Law Clerk to U.S. Circuit Judge Giles S. Rich. While an academic, he regularly served as a testifying and consulting expert, mediator, and arbitrator.
He studied law at Penn and biology and economics at MIT. He was recognized as one of the nation’s “Top 50 under 45” by the magazine IP Law & Business in 2008, and was inducted as a Member of the European Academy of Sciences and Arts in 2012.
Ranch Kimball helped move Massachusetts from hosting a research presence for only one of the world’s ten largest pharmaceutical firms, to today’s position hosting nine of the ten largest and 17 of the largest 20. For his sustained efforts, BIO awarded him its “Outstanding State Executive” national award.
He was a longtime Partner at BCG, and Managing Partner of a private equity firm, Kissinger McLarty Capital Group. He served as Governor Mitt Romney’s Secretary of Economic Development, then as President and CEO of one of the Harvard Research Hospitals, the Joslin Diabetes Center. He was a Managing Director for the Cambridge Innovation Center, with over 2,000 start-up companies in six buildings.
He led the Kendall Square CEO Council, and has been Board Chair of the Massachusetts Finance Authority, the Redevelopment Authority, the Airport and Seaport Authority, the Science Museum, Wheelock College, and vice-chair of the Museum of Fine Arts.
Dr. George Koomullil is the founder and CEO of Relecura Inc. George has 25 years of experience working in various roles in the invention ecosystem from research and product development to IP licensing, entrepreneurship and business development.
George founded Relecura Inc in 2009 with a desire to build an analytics platform that uses machine learning, semantic analysis, predictive analytics and knowledge management to process patents and patent portfolios. Relecura currently offers solutions on portfolio management, IP valuation, IP commercialization and competitive intelligence.
Prior to founding Relecura, George worked in IP licensing at IPValue Management, in product development at NXP Semiconductors, RF Micro Devices, Cadence Design Systems, and LogPoint Technologies, as well as in research positions at NASA Ames Research Center and Duke University. George received his PhD from Mississippi State University, MTech from IIT Chennai and BTech from the University of Kerala.
Matt Larson is the tech litigation analyst for Bloomberg Intelligence, a research platform that provides in-depth analysis and data sets on industries and companies, as well as the government, credit, litigation and economic factors that can impact decision-making. Mr. Larson’s research focuses on the impact of high-tech lawsuits and litigation trends on the financial markets. Prior to Bloomberg Intelligence, Mr. Larson worked as a patent attorney in Silicon Valley and Washington, D.C., representing clients in District Court, the U.S. Patent Office, and before the U.S. International Trade Commission.
Ron Laurie has worked in Silicon Valley since before it had that name, initially as a systems engineer and then as an intellectual property lawyer and patent strategist. In 2004, he launched Inflexion Point Strategy, the first IP investment bank, with offices in Silicon Valley, Taiwan and Singapore. Inflexion Point advises technology companies and institutional investors around the world in acquiring, divesting and investing in IP-rich companies, businesses units and technologies, and IP assets in the form of patent portfolios, exclusive field-of-use rights and related know-how.
Prior to launching Inflexion Point, Ron was a founding partner of Skadden Arps' Silicon Valley office, where he led IP teams in some of the largest high-tech and life sciences M&A, spin-out and joint venture deals ever done, worth over $50 billion in the aggregate. He was also a founding partner of the Silicon Valley offices of Weil, Gotshal and Irell & Manella
Ron is on the board of Wi-LAN, Inc., one of the oldest and most successful publicly-traded patent licensing companies.
Michael Lee is a director with Sterne, Kessler, Goldstein & Fox PLLC, a Washington DC-based IP specialty law firm. His practice focuses on working with clients to strategically patent and license their inventions in the United States and throughout the world.
He has considerable technical experience in the areas of computer processor and memory architectures; graphics processing units; communications, particularly wireless; optics; and analog and digital control systems. He has a particular focus in the software, e-commerce and financial services/business method areas, with 20 years of experience protecting such inventions in the United States and throughout the world.
Mr. Lee is counsel in over 30 inter partes review (IPR) and covered business method (CBM) review proceedings. He has been the lead attorney in over 30 inter partes reexaminations. Mr. Lee has worked on numerous district court litigations.
Mr. Lee is a Certified Licensing Professional (CLP) and an experienced IP transactions attorney. He has been named to IAM Strategy 300, IAM Licensing 250 and Managing Intellectual Property IP Stars. He assists clients with a wide range of technology-related transactions, including joint development agreements, strategic alliances, license agreements, technology transfer agreements, asset purchase agreements, contractor and services agreements, and manufacture/supply agreements.
Mr. Lee is a past President of CLP, and was on the board of the Licensing Executives Society (USA/Canada) for a number of years.
Mr. Lee earned his law degree from Georgetown University, and holds master and bachelor degrees in electrical engineering from the Universities of Maryland and Virginia, respectively. He is a member of Tau Beta Pi and Eta Kappa Nu.
Senior Managing Counsel for J. C. Penney Corporation, Inc., is responsible for all intellectual property litigation involving the company. Since joining JCPenney, Diane has handled more than 50 patent disputes and many copyright and trademark disputes. Diane joined JCPenney in 2010 after more than 25 years in private practice focused on intellectual property litigation, licensing and portfolio management. While in private practice, Diane represented clients that were intellectual property owners asserting rights against competitors, defendants accused of infringement by competitors, as well as clients accused of patent infringement by NPEs. Diane has testified before the Senate Judiciary Committee and a house subcommittee on proposed legislation relating to patent litigation and is a frequent speaker at senate and house staff briefings on proposed legislation. Diane also is frequent speaker at CLE events on issues relating to patent litigation and post grant review proceedings.
Justin Lewis is an experienced expert who has testified in both federal and state court. He is a Managing Director in Ocean Tomo’s Expert Services practice and leads the firm’s San Francisco office. His 19 years of consulting experience includes the analysis and quantification of economic damages arising from patent, trademark, trade secrets, copyright infringement & breach of contract in over a hundred matters. He has a solid understanding of the financial issues and theories related to intellectual property and breach of contract litigation from discovery to trial.
Mr. Lewis performed audits for two years with a big five accounting firm of the financial statements for both private and public companies. He is an experienced forensic accountant, conducting investigations in securities litigation matters including matters involving fortune 500.
Mr. Lewis is a Certified Public Accountant in California, Certified Valuation Analyst, Certified in Financial Forensics and holds a BS in Business/Economics.
Richard Lloyd is the North America editor of IAM, based in Washington DC. Before joining IAM in February 2014, he was a contributing editor to The American Lawyer and a freelance journalist. Prior to moving to the United States in 2011, Mr Lloyd was the editor of Legal Business and was previously chief European correspondent for The American Lawyer.
Judge Paul R. Michel served on the US Court of Appeals for the Federal Circuit for more than 22 years, the last 5 as Chief Judge, before retiring in May, 2010. He has presented to virtually very IP organization in the US. Since retiring from the court, he has provided consulting services to lawyers, including mediation, arbitration, case evaluation, mock trial, moot court, editing briefs and advising on strategy. He can be reached at firstname.lastname@example.org.
Michael Milani is a Managing Director in the Expert Testimony practice at Ocean Tomo. Michael’s professional background combines 20 years of litigation experience with 6 years of corporate strategy work. He provides financial analysis and related expert testimony on all types of IP matters, as well as other types of complex commercial litigation. He has testified in Federal Court, State Court, and ADR proceedings, and has evaluated commercial success, domestic industry, remedy and bond related issues for matters pending in Federal Court and/or the International Trade Commission. Michael holds a Bachelor of Science degree in Finance from the University of Illinois and a Masters in Business Administration from Northwestern University with concentrations in Finance, Marketing and Strategy. He is also a Certified Licensing Professional and serves as a member of the recertification committee.
Dmitry is Vice-President Business Development, in Qualcomm Technology Licensing at Qualcomm where he leads certain regional licensing efforts, as well as IoT licensing strategies. He has held roles in Qualcomm in various legal capacities for patent portfolio development for 4G technology, patent litigation and licensing. Prior to joining Qualcomm. Dmitry has worked in both private practice and in a start-up company leading its legal and licensing function. In private practice. Dmitry has led portfolio development, litigation and licensing efforts for small and mid-size semiconductor, electronics and software companies.
Dmitry received his law degree from Franklin Pierce Law Center in New Hampshire, and Electrical Engineering degree from Worcester Polytechnic Institute.
Tatiana Moore is an experienced technology business executive with twenty years of business development and intellectual property licensing experience at IBM and Microsoft. She brings strong leadership and deep transactional expertise combined with an extensive software development background and management skills to the deal making process. Since leaving Microsoft in late 2015, Ms. Moore established T.K. Moore Associates LLC, a business development and intellectual property licensing consulting practice. She serves on the Board of Governors of Certified Licensing Professionals, Inc. and is an Advisory Board Member of TurboPatent, a Voyager Capital portfolio company.
Ms. Moore joined Microsoft in January of 2004 to grow its corporate IP Group. As General Manager of IP Licensing responsible for outbound licensing of Microsoft’s corporate-wide IP assets, she led strategic deals, built licensing programs, launched the first patent litigations, assisted in settling EU undertaking and helped grow revenue 100-fold over the nine-year period. In addition, she was designated as Microsoft’s M&A IP expert as well as Litigation IP licensing expert. During this time, Ms. Moore served on the board of the Licensing Executives Society (LES) and the LES Foundation, and was the 2013 President and Chair of the Board of LES USA-Canada. In 2013, Ms. Moore transitioned to serve as GM of Business Development & Strategy for Microsoft Dynamics. She was responsible for driving technology acquisitions to expand the Dynamics enterprise application platforms through M&A and IP asset licensing as well as signing on key strategic industry partners increasing partner-led revenue of relevant Dynamics products 15-fold.
Ms. Moore’s career began at IBM in June of 1980, initially in technical software development and management roles. This included experience in all product lifecycle positions working on operating systems, Geographic Information Systems and supercomputing platforms, transitioning to OEM Sales. Ms. Moore joined IBM’s corporate IP group in 1997 to lead technology licensing deals, IP asset sales, joint development deals as well as IP portions of major divestitures and joint ventures, handling multi-million to multi-billion dollar transactions. She was a key contributor to generating $1-2B of IP licensing income annually for IBM.
Ms. Moore is a Certified Licensing Professional and was honored as a recipient of the IAM Strategy 300 Award (World's Leading IP Strategists) in 2015. Throughout her career, Ms. Moore had received numerous awards and recognition for innovative and first-of-a-kind projects as well as deal, team and management corporate awards. She is a frequent speaker at IP conferences and teacher of IP licensing and strategy. Adept at working with startups as well as Fortune 100 companies all over the globe, Ms. Moore excels at building consensus and lasting working and corporate relationships among diverse groups at every level.Tatiana Moore holds a Master of Science degree in Computer Science from NYU Polytechnic School of Engineering, a Bachelor of Arts degree in Mathematics from Fordham University, completed significant course work towards a Bachelor of Music degree (classical concert piano) from Manhattan School of Music.
Suzanne Munck is Chief Counsel for Intellectual Property for the United States Federal Trade Commission (FTC), and Deputy Director of its Office of Policy Planning. Ms. Munck frequently speaks about policy issues involving standard setting, patent assertion entities, and other issues at the intersection of antitrust and intellectual property. Ms. Munck also has significant experience litigating patent issues that arise during the FTC's enforcement efforts, particularly in the ICT and healthcare sectors. She has received the Commission’s Paul Rand Dixon and Janet D. Steiger awards. Before joining the FTC, Ms. Munck was a patent and antitrust litigator in Los Angeles. She received her BA in mathematics from Bryn Mawr College and her JD from the University of Minnesota Law School.
Dr. Sankara Narayanan is the VP of Business Development of Relecura Inc. Sankara has held various account management and business development leadership roles in technology companies managing major customers in US, Japan, China and India. He is adept in understanding customer business needs and pain points and working with technical experts to develop technology solutions to address them.
Sankara is excited to be part of the IP community and providing technology solutions for companies to maximize the value of their IP assets - IP analytics and research platform to build strong patent portfolios for competitiveness and revenue generation.
Sankara had worked in product and account management in Motorola and Nokia in Tokyo and Chicago. He had worked in software services sale in Persistent Systems in Bay Area and had done Robotics research in Japan. Sankara received his Ph.D. in robotics and Masters in Electronics from University of Waterloo in Canada and Bachelors in Engineering from University of Madras
Deanna Tanner Okun is a partner at Adduci, Mastriani & Schaumberg LLP. She has extensive experience as a top administrator, regulator, enforcer, legislative aide, and lawyer. Deanna served as a member of the U.S. International Trade Commission (ITC) from 2000-2012, including two terms as ITC Chairman, from 2004-2006 and from 2010-2012. During her tenure as a Commissioner, she ruled on hundreds of cases involving allegations of patent, trademark and copyright infringement as well as other types of unfair acts such as trade secrets. Drawing upon her experience in both the government and private sector, Deanna provides legal and strategic advice to steer companies through the intersection where innovation confronts barriers, such as intellectual property theft, unfair trade practices, or regulatory hurdles. In 2012, Deanna was named the Outstanding Woman of the Year by the Association of Women in International Trade, a chapter of the Organization of Women in International Trade. She has served on the Federal Circuit Advisory Council since 2013. In 2016, Managing Intellectual Property named Deanna one of the Top 250 Women in IP.
Jayson D. Pankin, Co-Founder, President and Chief Executive Officer, AutoHarvest Foundation About Jayson D. Pankin is a founder, President, and CEO of the nonprofit AutoHarvest Foundation. Jayson and his partner, Dr. David E. Cole created a unique innovation ecosystem led by some of the most highly respected figures in the automotive and manufacturing industries. In 2012, AutoHarvest.org was launched as the world’s only truly neutral and global on-line meeting place for innovators of all types with an interest in advanced manufacturing intellectual property. This system allows users of all types to showcase capabilities, technologies and needs system-wide and then privately connect with fellow inventors and commercializers to explore technology and business development opportunities. Partnered with the United States Patent and Trademark Office and the Departments of Defense, Energy and Homeland Security, AutoHarvest democratizes access across the innovation value chain—from grassroots entrepreneurs to corporate titans. From 2003-2010 he led Delphi Automotive’s commercialization activities targeting spin-outs of potentially disruptive technologies into start-up companies. For over thirty years, Jayson has been a venture partner specializing in early stage and turnaround situations. He was named by IAM Magazine as one of the World’s Leading IP Strategists in 2014, 2015 and 2016 and was the Small Business Foundation of Michigan’s “Intrapreneur Extraordinaire” for 2008. He has been featured by Accenture in its “Digital Shoring for Networked Innovation” as a Leading Thinker. He is a member of the International Committee of China’s International Technology Transfer Network. He earned his BBA in Accounting and MBA in International Business at the George Washington University. Jayson D. Pankin, Co-Founder, President and Chief Executive Officer, AutoHarvest Foundation About Jayson Jayson D. Pankin is a founder, President, and CEO of the nonprofit AutoHarvest Foundation. Jayson and his partner, Dr. David E. Cole created a unique innovation ecosystem led by some of the most highly respected figures in the automotive and manufacturing industries. In 2012, AutoHarvest.org was launched as the world’s only truly neutral and global on-line meeting place for innovators of all types with an interest in advanced manufacturing intellectual property. This system allows users of all types to showcase capabilities, technologies and needs system-wide and then privately connect with fellow inventors and commercializers to explore technology and business development opportunities. Partnered with the United States Patent and Trademark Office and the Departments of Defense, Energy and Homeland Security, AutoHarvest democratizes access across the innovation value chain—from grassroots entrepreneurs to corporate titans. From 2003-2010 he led Delphi Automotive’s commercialization activities targeting spin-outs of potentially disruptive technologies into start-up companies. For over thirty years, Jayson has been a venture partner specializing in early stage and turnaround situations. He was named by IAM Magazine as one of the World’s Leading IP Strategists in 2014, 2015 and 2016 and was the Small Business Foundation of Michigan’s “Intrapreneur Extraordinaire” for 2008. He has been featured by Accenture in its “Digital Shoring for Networked Innovation” as a Leading Thinker. He is a member of the International Committee of China’s International Technology Transfer Network. He earned his BBA in Accounting and MBA in International Business at the George Washington University.
John Paul has more than 30 years of experience in intellectual property licensing, litigation, and prosecution. He currently focuses on strategic planning, complex transactions, due diligence investigations, and licensing and enforcement of IP portfolios to generate revenue. He leads the firm's IP management and transaction section.
Mr. Paul has analyzed many patent portfolios for a wide range of companies and industries, including multimedia electronics, aerospace, medical devices, and consumer products. He has developed strategies and created systems to help companies understand and effectively communicate the legal and commercial significance of IP portfolios, develop more robust portfolios aligned with their business objectives, and generate revenue by monetizing those portfolios. He has set up and directed licensing and enforcement programs that generated significant royalty revenue for leading technology companies; set up and conducted multiple-round private auctions to sell patent portfolios; led negotiations related to IP issues in business divestitures and other complex transactions; conducted IP due diligence and negotiations for strategic acquisitions of patent portfolios; and negotiated and drafted a wide range of agreements relating to the development and use of intellectual property.
Mr. Paul serves as a board member and vice president of the Licensing Executives Society International and has served as counsel to the board, trustee, and vice president of the Licensing Executives Society U.S.A. and Canada. He frequently lectures on patent law, licensing, and IP management, and writes weekly articles for LES Insights on recent U.S. cases affecting licensing and other transactions.
Mike Perham has been the Head of Innovation Management at Janelia since the beginning of 2016. He brings a broad range of experience from industry and academia in technical and administrative roles. He handles technology management and dissemination and IP protection for Janelia in service of the Open Science initiative.
Prior to Janelia, he was Director of IP and Licensing at Health Diagnostic Laboratory, an innovative testing laboratory for cardiometabolic testing, and Director of IP and Commercial Contracts at ZyGEM/Microlab Diagnostics, a developer of reagents and rapid DNA analysis instrumentation. He previously handled academic technology transfer as a Licensing Associate at the University of Texas Medical Branch, the Rice University Office of Technology Transfer and the University of Virginia, where he started and managed the UVAPF Advisory Council.
Perham received his PhD in biophysical chemistry from Rice University, where, as a NIH Biotechnology Trainee and Keck Fellow in the Houston-Area Molecular Biophysics Program, he studied experimental protein folding among the broad training opportunities. Prior to grad school, he was a chemist at PPG Industries and received a BS in chemistry and BA in math from the University of Texas at Austin. His interests in technology and entrepreneurship have driven work for multiple startups and incubators in Virginia and Texas.
John Pisa-Relli is managing director of global trade compliance for Accenture, the world’s largest business consulting firm ($33 billion revenue in fiscal 16; over 400,000 employees in more than 50 countries; NYSE: ACN). In this role, he leads the company’s internal trade compliance program and an international legal team based in four continents. In 2016, John’s team was recognized by a leading law journal as one of the best in-house trade compliance departments in the world.
Previously, John managed the U.S. trade compliance program for a Fortune 500 aerospace and defense group headquartered in Europe. Also, he was an international trade lawyer in private practice and a case officer in the U.S. federal government. John speaks and writes frequently about corporate compliance and is co-author of the legal treatise UNITED STATES EXPORT CONTROLS.
At ktMINE, Eric is Director - IP Strategy & Valuation, specializing in technical demonstrations and consultations with over 12 years of experience in business intelligence and IP licensing. Eric worked as a Senior Patent Licensing Associate at Google working on patent acquisitions, securing licensing engagements, and procuring freedom of action, and prior to that at Motorola Mobile Devices as a Senior Manager of IP Licensing working on exposure analyses, industry profiles and acquisitions.
I graduated magna cum laude from Valparaiso University in 2010 with a JD/MBA. I am admitted to practice law in Massachusetts, Virginia and Washington D.C. I started with Feld Entertainment in 2011 and my title is Counsel for Talent and Licensing. Feld Entertainment is the worldwide leader in producing and presenting live touring family entertainment experiences in over 75 countries. Part of my position is to draft all the agreements for our merchandise licensing program for our Monster Jam, Ringling Bros. and Supercross properties that include toys with Mattel, video games, party supplies, clothing and all other merchandise around the world. I recently spoke about merchandise licensing at George Washington School of Law’s 1st Annual Entertainment Law Symposium. Finally, I am a qualified licensing practitioner through the Licensing Industry Merchandising Association.
Tim Ribelin is an Associate at Husch Blackwell, an industry-focused litigation and business law firm with offices in 18 cities across the United States.
Mr. Ribelin has published articles addressing various topics concerning healthcare law. A member of Husch Blackwell’s 2017 Healthcare Policy Initiative, he has co-authored a series of articles detailing healthcare policy changes and the impact of the repeal of the Affordable Care Act on different segments of the healthcare industry.
Mr. Ribelin earned a law degree from Baylor University School of Law, and holds a Master’s degree in Medicinal Chemistry from the University of Kansas. He worked in pharmaceutical research and development for five years, where he focused on the early-stage discovery of new antibiotics and oncology drugs. Additionally, Mr. Ribelin worked as a judicial extern for The Hon. U.S. Magistrate Jeff Manske in the U.S. District Court, Western District of Texas during law school.
As a National Security Agency (NSA) Senior Executive, Ms. Elizabeth Richards is the Senior Lead for Cyber at the Laboratory for Analytic Sciences, in Raleigh, North Carolina. Working with North Carolina State University, private industry partners, government personnel, and cyber defense stakeholders, Ms. Richards sets the research strategy and provides technical direction for the creation of leap-ahead analytic tradecraft and technology to advance the cyber defense mission.
Her technical expertise is rooted in novel implementation of advanced analytic techniques and algorithms, and evaluation of emerging computing technologies. She has been a key figure in creating partnerships with industry leaders to address the most challenging technical problems facing the Intelligence Community.
Ms. Richards holds a BA from The University of Illinois Champaign-Urbana, and an MS from The George Washington University. She has completed several Executive Education courses at Columbia University and The University of Michigan.
Hans Sauer is Deputy General Counsel and VP for Intellectual Property for the Biotechnology Innovation Organization, a major trade association representing over 1,000 biotechnology companies from the medical, agricultural, environmental and industrial sectors. At BIO, Mr. Sauer advises the organization's board of directors, amicus committee, and various staff committees on patent and other intellectual property-related matters. Prior to taking his current position at BIO in 2006, Mr. Sauer was Chief Patent Counsel for MGI Pharma, Inc., and Senior Patent Counsel for Guilford Pharmaceuticals Inc. Mr. Sauer has testified in both houses of Congress and regularly speaks on matters of life sciences patent policy. He holds a M.S. degree in biology from the University of Ulm in his native Germany; a Ph.D. in Neuroscience from the University of Lund, Sweden; and a J.D. degree from Georgetown University Law Center where he serves as adjunct professor.
Tom M. Schaumberg has litigated Section 337 unfair competition cases for over 35 years before the U.S. International Trade Commission (ITC) and has appeared before the Court of Appeals for the Federal Circuit (CAFC). He also uses his experience and his international, antitrust, business, and administrative law background to counsel clients regarding intellectual property matters. Tom has long been involved in shaping policies that have an impact on Section 337. Tom is a pioneer in creating opportunities at various trade bar groups and intellectual property associations for attorneys interested in promoting Section 337 as an effective border enforcement mechanism against unfair import competition. Tom is the editor of the American Bar Association-published book entitled “A Lawyer’s Guide to Section 337 Investigations Before the U.S. International Trade Commission.” Tom received his undergraduate degree from Yale and his law degree from Harvard.
Mark Schildkraut is Associate General Counsel-IP and Worldwide Cybersecurity Counsel at Becton, Dickinson and Company (BD), a Fortune 500 medical device and instrumentation technology company that develops, manufactures and sells medical devices, instrument systems and reagents.
Mark has responsibility for and leads a team of IP associates that handles intellectual property matters concerning BD’s Medical Segment, representing more than half of BD’s commercial offerings by revenue. These matters include patent and trade secret protection, drafting and negotiating technology and commercial agreements, product clearance and IP litigation.
Mark is also responsible for establishing legal strategy and counsel on enforcement issues relating to the infiltration of BD’s information network and product offerings and exfiltration of BD’s sensitive information. Particularly noteworthy was Mark’s involvement in BD v. Maniar and US v. Maniar, resulting in the guilty plea of two counts of theft and attempted theft of trade secrets. He has also been involved with criminal prosecutions in Utah and Illinois, as well as civil enforcement in China.
Mark has been an associate with BD’s Legal Department since 2005.
Prior to joining BD in 2005, Mark was an associate at Kaye Scholer LLP and Morgan & Finnegan LLP, focusing on patent litigation, IP clearance and prosecution matters. Mark received his J.D. from Fordham University’s School of Law and a B.S. in Electrical Engineering from the State University of New York at Buffalo.
Ronald J. Schutz is the Chair of the National IP and Technology Litigation Group, Managing Partner of the New York office, and a member of the Executive Board of Robins Kaplan LLP. He is a Fellow of the American College of Trial Lawyers and has been named by many publications as one of the top lawyers in the country. In 2008 the National Law Journal named him to its annual list of the Top 10 Winning Litigators in the United States.
Mr. Schutz has extensive trial experience. His significant judgments include: $110 million (Fonar v. GE); $89 million (Grantley v. Clear Channel); $35 million (St. Clair v. Canon); $25 million (St. Clair v. Sony); $12 million (Personal Audio v. Apple); and $6 million (Megdal v. La-Z-Boy).
Mr. Schutz received a B.S.M.E. degree from Marquette University and his J.D. from the University of Minnesota Law School.
Tim Seeley is Chief Counsel at Intellectual Ventures (IV) where his team, among other things, manages various post grant proceedings, including Inter Partes Reviews (IPRs), Covered Business Method Reviews (CBMs), and Reexaminations. Tim has been an attorney at IV since 2007, working in the Patent Prosecution Group, the Licensing Group, and the Litigation Group. Prior to IV, he was with Perkins Coie LLP where his practice included IP counseling, IP licensing, patent prosecution, and litigation. Tim holds a BS in aeronautical engineering, an MS in aerospace engineering, an MBA, and a JD. He is also a Certified Licensing Professional®, a graduate of the United States Air Force Test Pilot School, and a member of the Society of Experimental Test Pilots. Prior to practicing law, Tim worked in the aerospace industry as both a military and civilian experimental test pilot, an engineer, and a manager.
Baiju R. Shah is Chief Executive Officer of BioMotiv and co-leader of The Harrington Project for Discovery & Development, a $300 million US and UK drug development initiative. The Project’s mission is to accelerate breakthrough discoveries into medicines. It is advancing a portfolio of technologies through an innovative model that efficiently aligns capital and collaborations, including strategic partnerships with disease foundations, Takeda, Biogen, Arix Bioscience, and Charles River Laboratories.
Prior to BioMotiv, Mr. Shah was President and CEO of BioEnterprise, a business formation, recruitment and acceleration initiative. Over his tenure, the initiative assisted in the creation, recruitment, and acceleration of more than 110 bioscience companies in Cleveland that collectively attracted $1.3 Billion in new funding.
Shah serves on the Board of Invacare (NYSE: IVC) and on the Advisory Board for Citizens Financial Group (NYSE: CFG). Prior to founding BioEnterprise, he was a consultant with McKinsey & Company.
Shah has been named an Ernst & Young Entrepreneur of the Year. He received a J.D. from Harvard and a B.A. from Yale.
Shamoil T. Shipchandler is the Regional Director for the U.S. Securities and Exchange Commission’s Fort Worth Regional Office, where he leads the enforcement and examination activities in Texas, Oklahoma, Arkansas, and Kansas. Shamoil is formerly a Deputy Criminal Chief with the U.S. Attorney’s Office for the Eastern District of Texas, where he was the Attorney-in-Charge of the Plano Office, the Asset Forfeiture Chief, and prosecuted complex white collar criminal cases. During his tenure with the U.S. Attorney’s Office, Shamoil obtained convictions in the areas of securities and bank fraud, tax evasion, mail and wire fraud, money laundering, computer sabotage, and public corruption. Shamoil was a partner with Bracewell prior to joining the Commission and an associate with Covington & Burling before joining the U.S. Attorney’s Office. Shamoil graduated from Middlebury College and Cornell Law School, and clerked for Judge Roger B. Andewelt of the U.S. Court of Federal Claims.
Joe Sommer has been involved in various forms of monetization of AT&T’s patent assets and technology for over twenty years. He has participated in M&A transactions, standards consortium pool formations, patent valuations, managed company-wide defacto and standard based patent licensing programs, designed corporate-wide intellectual Property education courses, instituted and managed a Patent Sales Program, managed two full Patent Portfolio Analysis projects and created a portfolio taxonomy for an early instantiation of the AT&T portfolio for ease of analysis. Worked with venture capitalists to leverage portions of AT&T’s patent and technology asserts for high value.
Carl Spana, Ph.D., co-founder of Palatin, has been the Chief Executive Officer and President since June 14, 2000. He has been a director of Palatin since June 1996 and has been a director of our wholly-owned subsidiary, RhoMed Incorporated, since July 1995. From June 1996 through June 14, 2000, Dr. Spana served as an executive vice president and our chief technical officer. From June 1993 to June 1996, Dr. Spana was vice president of Paramount Capital Investments, LLC, a biotechnology and biopharmaceutical merchant banking firm, and of The Castle Group Ltd., a medical venture capital firm. Through his work at Paramount Capital Investments and The Castle Group, Dr. Spana co-founded and acquired several private biotechnology firms. From July 1991 to June 1993, Dr. Spana was a Research Associate at Bristol-Myers Squibb, a publicly-held pharmaceutical company, where he was involved in scientific research in the field of immunology. He was previously a member of the board of the life science company AVAX Technologies, Inc.
Dr. Spana received his Ph.D. in molecular biology from the Johns Hopkins University and his B.S. in biochemistry from Rutgers University.
Michael P. Straightiff joined the University of Virginia Licensing & Ventures Group as director in September 2011.
Previously, as director of biomedical engineering commercialization in Case Western Reserve University's Technology Transfer Office, Straightiff managed high-profile research, development and commercialization partnerships with several large biomedical technology companies. He was also involved in the formation of companies spun out of Case, in coordination with Case Technology Ventures and the local investment community. Straightiff served on the board of directors for a venture-backed neurostimulation company and an early-stage biomedical imaging company. At Case, Straightiff also served on the institutional oversight committee for the school's Wallace H. Coulter Translational Research Partnership.
Straightiff formerly was a senior licensing associate and a consultant for Virginia Tech Intellectual Properties Inc., where he managed a diverse portfolio of technologies in engineering, physical sciences and life sciences. He also worked as a patent examiner for the U.S. Patent and Trademark Office after serving as research assistant at the Cleveland Functional Electrical Stimulation Center.
M.B.A., Case Western Reserve University; Master of Public Policy, George Mason University; B.S., Biomedical Engineering, Case Western Reserve University
Philip Strassburger has served as Sr. Vice President and General Counsel from 2012-2017. He is also the Chief International Intellectual Property Counsel. He joined Purdue in 1999 after serving as Senior Patent Counsel at Pfizer Inc, and as an Associate at the New York law firms of Hedman Gibson, and Bryan Cave LLP. Before he began his legal career, Mr. Strassburger practiced as a chemical engineer in The Netherlands.
Mr. Strassburger began his career at Purdue as Chief Patent Counsel, and was later named Vice President, Intellectual Property Counsel. At Purdue, Mr. Strassburger has worldwide responsibility for intellectual property prosecution and litigation. He has negotiated numerous acquisitions, licenses, and patent settlements throughout the world. He is also responsible for all legal affairs of Purdue, including antitrust, transactional, and regulatory legal matters in the United States.
Mr. Strassburger received his BS degree in Chemical Engineering and his BA in Philosophy from Tufts University, and a Juris Doctorate degree from the University of Connecticut. He is admitted to practice in New York and Connecticut as well as the U.S. Patent and Trademark Office.
A partner in Venable’s Regulatory Group, David Strickland focuses his practice on transportation policy, consumer protection, internet privacy, data security, and legislative and government affairs. He has significant federal government and private practice experience. Most recently, Mr. Strickland served as the fourteenth Administrator of the National Highway Traffic Safety Administration (NHTSA). As the top automotive safety official in the United States, he was responsible for fulfilling the agency's mission to reduce crash-related fatalities and injuries while ensuring the highest standards of safety on the nation's roads. Mr. Strickland oversaw a broad range of vehicle safety and policymaking programs, including setting vehicle safety standards, investigating possible safety defects, and tracking safety-related recalls; annually distributing over $600 million in highway safety grants to states and leading the behavioral safety program; and establishing and enforcing the regulations on fuel economy. His major accomplishments at NHTSA include overseeing the development of the first national fuel economy programs for both passenger vehicles and heavy-duty trucks in conjunction with the Environmental Protection Agency, and implementing the vehicle safety and highway safety grant mandates included in the 2012 Highway Reauthorization (MAP-21). He also issued the first ejection mitigation standards for passenger vehicles to help keep passengers from being partially or fully ejected from vehicles during a rollover crash; mandated that lap and shoulder belts be installed on all new motorcoaches; launched the nation’s largest connected vehicle (V2V) safety pilot program; and issued the first automated vehicle policy. In addition, Mr. Strickland brought national attention to child passenger safety issues and was a leader in the campaigns to fight impaired and distracted driving.
Mr. Tang is currently the Licensing and Commercialization Manager at the Gas Technology Institute (GTI), a contract research organization for the natural gas industry. At GTI, Mr. Tang works with senior executives to identify technologies to commercialize through licensing, JVs, or spinouts. Over the past 3 years he has negotiated, structured, and executed over 25 agreements. He was a co-founder of Invention Bridge and launched Clean Energy Trust, a non-profit cleantech accelerator founded by Nick Pritzker and Michael Polsky. Mr. Tang brings private equity experience from McNally Capital and MVC Capital. Prior to business school, Mr. Tang was a Senior Manager at STAX Inc. Mr. Tang began his career at Open Prairie Ventures, an early stage SBIC venture capital fund that specializes in developing spinout ventures from research institutions. Mr. Tang earned an MS and BS in Mechanical Engineering from the University of Illinois at Urbana-Champaign and an MBA from the University of Chicago Booth School of Business.
Dr. Wald is an intellectual property professional responsible for business value creation for Visa through the strategic use of intellectual property. He focuses on the development and management of Visa's patent portfolio and trade secrets, the management of intellectual property risks. Before joining Visa he co-led Intellectual Property Management Services at Ernst & Young and was Director of Intellectual Property Strategy and Licensing at Honeywell.
Dr. Lynne Weber is a managing director in the Strategic Value Advisory practice of Duff & Phelps with 36 years of consulting experience involving analysis of marketing, product development, partnering, M&A and/or business strategies. She also develops financial projections and conducts commercial due diligence to support IP valuation, licensing negotiations, acquisition of IP portfolios, capital-raising and IP investment strategy.
Lynne also served as a subject matter expert/co-author for the Appraisal Foundation Board’s guidance on the Valuation of Contingent Consideration. She provides expert reports and testimony on patent, contract, anti-trust, trademark, false advertising, trade secret and product liability disputes.
Prior to joining Duff & Phelps, Lynne was a managing director at Standard & Poor’s, a principal at PricewaterhouseCoopers LLP and a principal at Applied Decision Analysis, Inc. Lynne received her Ph.D. in operations research and her M.S. in statistics from Stanford University and her B.A. in math from Cornell University.